enVVeno Medical (NVNO) Other Accumulated Expenses (2020 - 2026)

enVVeno Medical (NVNO) posted quarterly Other Accumulated Expenses of $112000.0 for Q2 2026, up 38.27% quarter-over-quarter from $81000.0 in Q1 2026.

enVVeno Medical (NVNO) Other Accumulated Expenses (2020 - 2026) Analysis & Trends

enVVeno Medical's Other Accumulated Expenses history runs 6 years deep, the most recent figure standing at $112000.0 for Q2 2026.

In Q2 2026, Other Accumulated Expenses changed N/A year-over-year to $112000.0; the TTM figure through Jun 2026 stood at $112000.0 (changed N/A YoY), while the FY2025 annual figure was $134000.0, up 10.74% from the prior year.
Other Accumulated Expenses for Q2 2026 stood at $112000.0, up from $81000.0 in the prior quarter.
The five-year high for Other Accumulated Expenses was $134000.0 in Q4 2025, with the low at $59000.0 in Q2 2022.
The 4-year median for Other Accumulated Expenses is $96500.0 (2026), against an average of $94500.0.
Peak annual rise in Other Accumulated Expenses reached 10.74% in 2025, while the deepest fall reached 10.74% in 2025.
enVVeno Medical's Other Accumulated Expenses stood at $59000.0 in 2022, then jumped by 105.08% to $121000.0 in 2024, then climbed by 10.74% to $134000.0 in 2025, then fell by 16.42% to $112000.0 in 2026.
Business Quant data shows NVNO's Other Accumulated Expenses at $112000.0 in Q2 2026, $81000.0 in Q1 2026, and $134000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	enVVeno Medical	7.04 Mn	7.04 Mn	-

Download Data